Private Market View

Capital Science and Technology Development Group

Other · Beijing, China

AUM
Portfolio companies
21
Recorded deals
Last investment

Key facts

  • Capital Science and Technology Development Group is a other based in Beijing, China with 21 tracked portfolio companies.
  • Notable positions include Linkerbot, PrimeGene (Beijing), Carbon Energy Technology, Immunochina Pharmaceuticals, HinGear.

About Capital Science and Technology Development Group

Capital Science and Technology Development Group is a government agency based in Beijing, China. Established in 2014, the agency primarily operates in technology innovation and commercialization, focusing on transforming research achievements into market-ready solutions. Their core business areas include venture investment in emerging industries such as biomedicine, new materials, AI, aerospace, and clean energy; pre-incubation services to support early-stage technologies; and innovation ecosystem development to strengthen Beijing's role as a global science and technology hub. The assets are managed by the executive management team.

Free account
See the whole book
  • ·The book's top 25 — of 21 recorded positions
  • ·Watchlist + alerts for Capital Science and Technology Development Group's activity
Create free account
No card required

Portfolio, priced

21 companies · by our current valuations
CompanyValuationRole
Linkerbot$287.6M
PrimeGene (Beijing)$248.0M
Carbon Energy Technology$222.1M
Immunochina Pharmaceuticals$215.3M
HinGear$41.9M
Wavarts$17.7M
Flightwin
Hurrichip
Inno Medicine
Space Pioneer Technology
Suzhou Panier Medical Technology
Weichong Semiconductor
Yanshengchao
Yuanli Semiconductor
Beiqi Biology
+ 6 more companies · a free account shows the top of the book

Frequently asked

What companies does Capital Science and Technology Development Group invest in?
Capital Science and Technology Development Group has 21 recorded portfolio companies, including Linkerbot, PrimeGene (Beijing), Carbon Energy Technology, Immunochina Pharmaceuticals.